{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:52:32Z","timestamp":1791215552117,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hospital Infection"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.jhin.2009.02.021","type":"journal-article","created":{"date-parts":[[2009,7,11]],"date-time":"2009-07-11T04:35:59Z","timestamp":1247286959000},"page":"345-354","source":"Crossref","is-referenced-by-count":282,"title":["Extended-spectrum \u03b2-lactamase-producing organisms"],"prefix":"10.1016","volume":"73","author":[{"given":"M.E.","family":"Falagas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.E.","family":"Karageorgopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhin.2009.02.021_bib1","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1128\/AAC.39.6.1211","article-title":"A functional classification scheme for beta-lactamases and its correlation with molecular structure","volume":"39","author":"Bush","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhin.2009.02.021_bib2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/222024a0","article-title":"Chemical structure of bacterial penicillinases","volume":"222","author":"Ambler","year":"1969","journal-title":"Nature"},{"key":"10.1016\/j.jhin.2009.02.021_bib3","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1056\/NEJMra041359","article-title":"The new beta-lactamases","volume":"352","author":"Jacoby","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhin.2009.02.021_bib4","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1128\/AAC.00883-08","article-title":"Characterization and sequence analysis of extended spectrum \u03b2-lactamase encoding genes from Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis isolates collected during tigecycline phase 3 clinical trials","volume":"53","author":"Jones","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhin.2009.02.021_bib5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/jac\/dkl483","article-title":"CTX-M: changing the face of ESBLs in Europe","volume":"59","author":"Livermore","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jhin.2009.02.021_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.48.1.1-14.2004","article-title":"Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes","volume":"48","author":"Bonnet","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhin.2009.02.021_bib7","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1093\/jac\/dkm310","article-title":"Antimicrobial susceptibility among organisms from the Asia\/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline","volume":"60","author":"Reinert","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jhin.2009.02.021_bib8","unstructured":"Hackel M, Badal R, Bouchillon S, et\u00a0al. Extended-spectrum beta-lactamase production in Europe. In: Abstracts of the 18th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Barcelona, Spain, 2008."},{"key":"10.1016\/j.jhin.2009.02.021_bib9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1473-3099(08)70041-0","article-title":"Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern","volume":"8","author":"Pitout","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jhin.2009.02.021_bib10","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1128\/AAC.00576-07","article-title":"First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system","volume":"51","author":"Lewis","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl. 1","key":"10.1016\/j.jhin.2009.02.021_bib11","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1469-0691.2007.01846.x","article-title":"Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide","volume":"14","author":"Drieux","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhin.2009.02.021_bib12","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1128\/JCM.01988-06","article-title":"Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures","volume":"45","author":"Wiegand","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jhin.2009.02.021_bib13","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1001\/archinte.168.17.1897","article-title":"Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli","volume":"168","author":"Rodriguez-Bano","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jhin.2009.02.021_bib14","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","article-title":"Extended-spectrum beta-lactamases: a clinical update","volume":"18","author":"Paterson","year":"2005","journal-title":"Clin Microbiol Rev"},{"issue":"Suppl. 1","key":"10.1016\/j.jhin.2009.02.021_bib15","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1469-0691.2007.01850.x","article-title":"Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe","volume":"14","author":"Canton","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhin.2009.02.021_bib16","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/jac\/dkn293","article-title":"Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology","volume":"62","author":"Rodriguez-Bano","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jhin.2009.02.021_bib17","first-page":"409","article-title":"Clinical Microbiology and Infectious Diseases (ECCMID) \u2013 18th European Congress. Drug resistance among Gram-negative and Gram-positive bacteria","volume":"11","author":"Falagas","year":"2008","journal-title":"IDrugs"},{"key":"10.1016\/j.jhin.2009.02.021_bib18","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/jac\/dkm403","article-title":"Complex molecular epidemiology of extended-spectrum beta-lactamases in Klebsiella pneumoniae: a long-term perspective from a single institution in Madrid","volume":"61","author":"Valverde","year":"2008","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl. 1","key":"10.1016\/j.jhin.2009.02.021_bib19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1469-0691.2007.01862.x","article-title":"Extended-spectrum beta-lactamases in long-term-care facilities","volume":"14","author":"Nicolas-Chanoine","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhin.2009.02.021_bib20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1086\/498519","article-title":"Clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli as a cause of nosocomial infection or colonization: implications for control","volume":"42","author":"Rodriguez-Bano","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 4","key":"10.1016\/j.jhin.2009.02.021_bib21","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1086\/500662","article-title":"Overview of the epidemiological profile and laboratory detection of extended-spectrum beta-lactamases","volume":"42","author":"Pfaller","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhin.2009.02.021_bib22","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/jac\/dkm318","article-title":"Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis","volume":"60","author":"Schwaber","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jhin.2009.02.021_bib23","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1473-3099(08)70279-2","article-title":"Current control and treatment of multidrug-resistant Acinetobacter baumannii infections","volume":"8","author":"Karageorgopoulos","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jhin.2009.02.021_bib24","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/CCM.0B013E3181652FAE","article-title":"Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case\u2013control study","volume":"36","author":"Matthaiou","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jhin.2009.02.021_bib25","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/jac\/dkn164","article-title":"Control of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae using a computer-assisted management program to restrict third-generation cephalosporin use","volume":"62","author":"Kim","year":"2008","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl. 1","key":"10.1016\/j.jhin.2009.02.021_bib26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1469-0691.2007.01864.x","article-title":"Antibiotic policy and prescribing strategies for therapy of extended-spectrum beta-lactamase-producing Enterobacteriaceae: the role of piperacillin-tazobactam","volume":"14","author":"Peterson","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhin.2009.02.021_bib27","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/jac\/dkm356","article-title":"Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study","volume":"60","author":"Falagas","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jhin.2009.02.021_bib28","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.diagmicrobio.2006.06.015","article-title":"Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli","volume":"56","author":"Bin","year":"2006","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jhin.2009.02.021_bib29","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1469-0691.2005.01290.x","article-title":"High-dose cefepime as an alternative treatment for infections caused by TEM-24 ESBL-producing Enterobacter aerogenes in severely-ill patients","volume":"12","author":"Goethaert","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhin.2009.02.021_bib30","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1128\/AAC.47.11.3442-3447.2003","article-title":"Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized study","volume":"47","author":"Zanetti","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhin.2009.02.021_bib31","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1128\/JCM.39.6.2206-2212.2001","article-title":"Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory","volume":"39","author":"Paterson","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jhin.2009.02.021_bib32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1086\/324742","article-title":"Molecular correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime","volume":"34","author":"Wong-Beringer","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhin.2009.02.021_bib33","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1128\/AAC.37.4.851","article-title":"Kinetic interactions of tazobactam with beta-lactamases from all major structural classes","volume":"37","author":"Bush","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhin.2009.02.021_bib34","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1128\/AAC.38.4.767","article-title":"Comparative activities of clavulanic acid, sulbactam, and tazobactam against clinically important beta-lactamases","volume":"38","author":"Payne","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhin.2009.02.021_bib35","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1592\/phco.23.12.1232.32706","article-title":"Clinical and microbiologic analysis of a hospital's extended-spectrum beta-lactamase-producing isolates over a 2-year period","volume":"23","author":"Burgess","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jhin.2009.02.021_bib36","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1128\/AAC.47.5.1643-1646.2003","article-title":"Pharmacokinetics-pharmacodynamics of cefepime and piperacillin-tazobactam against Escherichia coli and Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases: report from the ARREST program","volume":"47","author":"Ambrose","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhin.2009.02.021_bib37","first-page":"CR75","article-title":"Antimicrobial resistance of Esherichia coli urinary isolates from primary care patients in Greece","volume":"14","author":"Falagas","year":"2008","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.jhin.2009.02.021_bib38","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/jac\/dkl381","article-title":"Treatment of ESBL-producing Klebsiella pneumoniae bacteraemia with carbapenems or flomoxef: a retrospective study and laboratory analysis of the isolates","volume":"58","author":"Lee","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jhin.2009.02.021_bib39","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/jac\/dkm215","article-title":"Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamases","volume":"60","author":"Lee","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jhin.2009.02.021_bib40","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1086\/380645","article-title":"Bacteremia due to Klebsiella pneumoniae isolates producing the TEM-52 extended-spectrum beta-lactamase: treatment outcome of patients receiving imipenem or ciprofloxacin","volume":"38","author":"Endimiani","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhin.2009.02.021_bib41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/420816","article-title":"Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases","volume":"39","author":"Paterson","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhin.2009.02.021_bib42","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/jac\/dkm180","article-title":"Efficacy of ertapenem in the treatment of early ventilator-associated pneumonia caused by extended-spectrum beta-lactamase-producing organisms in an intensive care unit","volume":"60","author":"Bassetti","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jhin.2009.02.021_bib43","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1053\/jhin.2002.1288","article-title":"Clinical implications of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteraemia","volume":"52","author":"Kim","year":"2002","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jhin.2009.02.021_bib44","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.1128\/AAC.48.12.4574-4581.2004","article-title":"Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy","volume":"48","author":"Kang","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhin.2009.02.021_bib45","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/138920009787048356","article-title":"Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of tigecycline","volume":"10","author":"Falagas","year":"2009","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.jhin.2009.02.021_bib46","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/jac\/dkn311","article-title":"Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies","volume":"62","author":"Kelesidis","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jhin.2009.02.021_bib47","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1469-0691.2005.01351.x","article-title":"Global assessment of the antimicrobial activity of polymyxin B against 54\u2008731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001\u20132004)","volume":"12","author":"Gales","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhin.2009.02.021_bib48","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10096-007-0456-4","article-title":"Antimicrobial susceptibility of multidrug-resistant Gram negative bacteria to fosfomycin","volume":"27","author":"Falagas","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jhin.2009.02.021_bib49","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1086\/527442","article-title":"Fosfomycin: use beyond urinary tract and gastrointestinal infections","volume":"46","author":"Falagas","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.jhin.2009.02.021_bib50","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1469-0691.2007.01852.x","article-title":"Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline","volume":"14","author":"Garau","year":"2008","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl. 1","key":"10.1016\/j.jhin.2009.02.021_bib51","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1469-0691.2007.01857.x","article-title":"Defining an extended-spectrum beta-lactamase","volume":"14","author":"Livermore","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhin.2009.02.021_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkn444","article-title":"Redefining extended-spectrum beta-lactamases: balancing science and clinical need","volume":"63","author":"Giske","year":"2009","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Hospital Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195670109001777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195670109001777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T07:50:00Z","timestamp":1545119400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0195670109001777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0195670109001777"],"URL":"https:\/\/doi.org\/10.1016\/j.jhin.2009.02.021","relation":{},"ISSN":["0195-6701"],"issn-type":[{"value":"0195-6701","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}